Skip to content

Clinical trials

Hemorrhage trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Czechia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20093
20142
20181
20191
20204
20226
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bioster, a.s.2
Idorsia Pharmaceuticals Ltd.2
University Hospital, Motol2
Abbott Medical Devices1
Anthos Therapeutics, Inc.1
AstraZeneca1
Bayer1
Boehringer Ingelheim1
Brno University Hospital1
Charles University, Czech Republic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage20
Stroke4
Atrial Fibrillation2
Hemostatic Disorders2
Myocardial Infarction2
Subarachnoid Hemorrhage2
Surgical Wound2
Aortic Valve Disease1
Aortic Valve Stenosis1
Blood Loss, Surgical1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.